PSYCHOGENICS, INC.

Biotech · Private

Platform for identifying and developing medications to treat nicotine addiction

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Total capital: $4.4M

Federal grants: $4.4M; 9 awards · 2015–2026; Rank in peer group#8 of 36
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 13 pending

Capital timeline

Latest events

Jun 2026Federal grantHealth and Human S · Phase I · TAAR1 Agonists for the Treatment of Stimulant Use Disorder$399K
Sep 2025Federal grantHealth and Human S · Phase II · Development of a Drug Candidate for the Treatment of Agitation in Alzheimer's Disease$496K
Jun 2025Federal grantHealth and Human S · Phase II · EEG Signature Analysis for Drug Repurposing for Rare Diseases$460K
Aug 2024Federal grantHealth and Human S · Phase II · EEG Signature Analysis for Drug Repurposing for Rare Diseases$561K
Jul 2024Federal grantHealth and Human S · Phase I · Machine Learning Phenotypic De Novo Drug Design$500K
Aug 2023Federal grantHealth and Human S · Phase I · Machine Learning Phenotypic De Novo Drug Design$500K
Dec 2019Federal grantHealth and Human S · Phase I · Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders$88K

Show 2 earlier federal awards

Jul 2019Federal grantHealth and Human S · Phase I · Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders$450K
Jul 2015Federal grantHealth and Human S · Phase II · Predictive Smoking Cessation Preclinical Battery$916K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 36 peers

Line = median

Biotech · Platform

Federal grants#8 · top 22%
Linked publications#2 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 13

Sep 6, 2018PendingTreatment of Motor and Movement Disorder Side Effects Associated with Parkinson's Disease TreatmentsUSPTOApplication 15971222
Aug 16, 2018PendingTreatment for Neurological and Mental DisordersUSPTOApplication 15951684
Mar 10, 2016PendingTreatment for Neurological and Mental DisordersUSPTOApplication 14945013

Show all 13 patent records

Treatment of Motor and Movement Disorder Side Effects Associated with Parkinson's Disease TreatmentsSep 6, 2018 · Application 15971222Pending
Treatment for Neurological and Mental DisordersAug 16, 2018 · Application 15951684Pending
Treatment for Neurological and Mental DisordersMar 10, 2016 · Application 14945013Pending
Treatment of Motor and Movement Disorder Side Effects Associated with Parkinson's Disease TreatmentsDec 12, 2013 · Application 13911639Pending
Compounds And Methods For The Treatment Of Attention-deficit Hyperactivity DisorderApplication PCTUS2004032632Pending
System And Method For Assessing Motor And Locomotor Deficits And Recovery TherefromApplication PCTUS2004018046Pending
Treatment For Attention-deficit Hyperactivity DisorderApplication PCTUS2004002793Pending
Systems And Methods For Monitoring Behavior InformaticsApplication PCTUS2002015700Pending
Computer-based Systems For Acquiring And Analyzing Observational Subject DataApplication PCTUS2022081831Pending
Systems And Methods For Monitoring Behavior InformaticsApplication PCTUS2002015981Pending
Treatment Of Motor And Movement Disorder Side Effects Associated With Parkinson's Disease TreatmentsApplication PCTUS2013044509Pending
Multicyclic Compounds And Methods Of Use ThereofApplication PCTUS2010058884Pending
Treatment For Neurological And Mental DisordersApplication PCTUS2009045221Pending

Recent research by its founders

Cultivation and molecular profiling reveal ammonia-oxidizing archaea as skin commensals20260 cites
Application of preclinical gene therapy approaches20250 cites
Comparative analysis of human and mouse fibroblast lines as in vitro models for lysosomal storage diseases: A focus on enzyme activity and lipid metabolism20250 cites

PRECISION VIROLOGICS INCSimilar federal contract value in Biotech · null in contracts
CYTORUM, INC.Similar federal contract value in Biotech · null in contracts
LOXAGEN INC.Similar federal contract value in Biotech · null in contracts
JILLION THERAPEUTICS INC.Similar federal contract value in Biotech · null in contracts
ILLUMINATE THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
MERLIN THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.